​

Tekla Life Sciences Investors Ownership | Who Owns Tekla Life Sciences Investors?

OverviewChart

Tekla Life Sciences Investors Ownership Summary

Tekla Life Sciences Investors is owned by 16.01% institutional investors, and 83.99% retail investors. Saba capital management is the largest institutional shareholder, holding 8.96% of HQL shares.

HQL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTekla Life Sciences Investors16.01%-83.99%
SectorFinancial Services Stocks 32.19%15.44%52.37%
IndustryAsset Management Stocks45.25%8.61%46.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Saba capital management2.59M8.96%$40.12M
Morgan stanley1.16M4.03%$19.55M
Penserra capital management875.13K3.03%$14.68M
Lpl financial478.80K1.66%$7.79M
Raymond james financial423.03K1.47%$6.56M
Needham investment management403.36K1.40%$6.26M
Flagship harbor advisors382.72K1.33%$6.23M
Allspring global investments362.54K1.26%$5.90M
Rivernorth capital management307.64K1.07%$4.77M
Bank of america corp /de/217.43K0.80%$3.08M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Saba capital management2.59M1.10%$40.12M
Shaker financial services115.42K0.61%$1.94M
Needham investment management403.36K0.44%$6.26M
Formidable asset management158.38K0.41%$2.66M
180 wealth advisors149.56K0.28%$2.43M
Flagship harbor advisors382.72K0.27%$6.23M
Rivernorth capital management307.64K0.27%$4.77M
Blue bell private wealth management77.07K0.19%$1.29M
Penserra capital management875.13K0.17%$14.68M
1607 capital partners122.17K0.14%$1.89M

Top Buyers

HolderShares% AssetsChange
Morgan stanley1.16M0.00%294.17K
Allspring global investments362.54K0.01%132.10K
Penserra capital management875.13K0.17%80.99K
Rivernorth capital management307.64K0.27%77.79K
Raymond james financial423.03K0.00%47.07K

Top Sellers

HolderShares% AssetsChange
Saba capital management2.59M1.10%-430.89K
Sit investment associates---417.06K
Royal bank of canada79.25K0.00%-372.09K
Karpus management---300.28K
Rpo---259.27K

New Positions

HolderShares% AssetsChangeValue
Absolute investment advisers35.76K0.07%35.76K$581.73K
Independent financial group12.98K0.01%12.98K$211.20K
Wealth enhancement advisory services10.69K0.00%10.69K$179.96K
Fifth third bancorp874.00-874.00$14.23K
Rockefeller capital management642.00-642.00$9.96K

Sold Out

HolderChange
Quent capital-1.00
Fmr-2.00
Jpmorgan chase-5.00
Washington trust-10.00
Ifp advisors-22.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202553-35.37%4,622,819-49.40%161.60%26-43.48%13-31.58%
Sep 30, 2025808.11%9,112,7308.56%313.71%44-1958.33%
Jun 30, 202574-9.76%9,142,3903.05%313.18%43-12.24%13-27.78%
Mar 31, 20258012.68%8,797,375-6.51%312.79%4860.00%18-5.26%
Dec 31, 202442-43.24%2,335,181-76.22%80.65%15-48.28%12-58.62%

Insider Transactions Trends

DateBuySell
2025 Q41-
2025 Q3-11
2025 Q2-14
2025 Q1-14
2024 Q4--

HQL Ownership FAQ

Who Owns Tekla Life Sciences Investors?

Tekla Life Sciences Investors shareholders are primarily institutional investors at 16.01%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Tekla Life Sciences Investors's industry, Asset Management Stocks, is 45.25%, which Tekla Life Sciences Investors falls below.

Who owns the most shares of Tekla Life Sciences Investors?

Tekla Life Sciences Investors’s largest shareholders are Saba capital management (2.59M shares, 8.96%), Morgan stanley (1.16M shares, 4.03%), and Penserra capital management (875.13K shares, 3.03%). Together, they hold 16.02% of Tekla Life Sciences Investors’s total shares outstanding.

Does Blackrock own Tekla Life Sciences Investors?

BlackRock is not among the top 10 institutional shareholders of Tekla Life Sciences Investors.

Who is Tekla Life Sciences Investors’s biggest shareholder by percentage of total assets invested?

Saba capital management is Tekla Life Sciences Investors’s biggest shareholder by percentage of total assets invested, with 1.10% of its assets in 2.59M Tekla Life Sciences Investors shares, valued at 40.12M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools